Gagnon Robert E.
Opus Genetics, Inc. · Chief Financial Officer
Gagnon Robert E. is listed in filings as Chief Financial Officer at Opus Genetics, Inc.. This profile follows SEC Form 4 activity through Apr 27, 2026, including sale activity. Recent filings connect the profile to Opus Genetics, Inc. (IRD), Verastem, Inc. (VSTM), Harvard Bioscience, Inc. (HBIO), and Bone Biologics Corporation (BBLGW). The current snapshot covers public activity from Jun 20, 2024 to Apr 27, 2026. Reported amounts are shown as $40.7K to $2.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $2.6k283 shares | SellDec 16, 2025 | $9.14 | $5.77 | |
| $2.8k281 shares | SellSep 16, 2025 | $9.99 | $5.77 | |
| $1.6k284 shares | SellJun 16, 2025 | $5.65 | $5.77 | |
| $2k284 shares | SellMar 17, 2025 | $6.95 | $5.77 | |
| $568130 shares | SellDec 19, 2024 | $4.37 | $5.77 | |
| $1.3k285 shares | SellDec 16, 2024 | $4.54 | $5.77 | |
| $365131 shares | SellSep 19, 2024 | $2.79 | $5.77 | |
| $804287 shares | SellSep 16, 2024 | $2.80 | $5.77 | |
| $421131 shares | SellJun 20, 2024 | $3.21 | $5.77 | |
| $988283 shares | SellJun 17, 2024 | $3.49 | $5.77 |